1. Zhang, Bing, Wang, Jing, Wang, Xiaojing, Slebos, Robbert J C, Liebler, Daniel C. 2014. Proteogenomic characterization of human colon and rectal cancer. In Nature, 513, 382-7. doi:10.1038/nature13438. https://pubmed.ncbi.nlm.nih.gov/25043054/
2. Xing, Lu, Zeng, Rui, Huang, Kai, Hu, Xudong, Liu, Chenghai. 2022. Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes. In Frontiers in pharmacology, 13, 907921. doi:10.3389/fphar.2022.907921. https://pubmed.ncbi.nlm.nih.gov/36249820/
3. Li, Zhigui, Yang, Hongzhao, Liu, Jianbo, Li, Li, Wang, Xiaodong. 2023. TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer. In Frontiers in oncology, 13, 947364. doi:10.3389/fonc.2023.947364. https://pubmed.ncbi.nlm.nih.gov/36845719/
4. Blesa, José R, Prieto-Ruiz, Jesús A, Abraham, Beth A, Hegde, Anita A, Hernández-Yago, José. . NRF-1 is the major transcription factor regulating the expression of the human TOMM34 gene. In Biochemistry and cell biology = Biochimie et biologie cellulaire, 86, 46-56. doi:10.1139/o07-151. https://pubmed.ncbi.nlm.nih.gov/18364745/
5. Shi, Qiwen, Zhang, Pengfei, Hu, Qingtao, Zhu, Wenting, Qi, Nan. 2024. Role of TOMM34 on NF-κB activation-related hyperinflammation in severely ill patients with COVID-19 and influenza. In EBioMedicine, 108, 105343. doi:10.1016/j.ebiom.2024.105343. https://pubmed.ncbi.nlm.nih.gov/39276680/
智鼠故事 
